Antiphospholipid syndrome and acute myocardial infarction: Treatment with thrombectomy and abciximab
Revista Portuguesa de Cardiologia, 2014 Antiphospholipid syndrome (APS) is an autoimmune coagulation disorder that manifests clinically as venous and arterial thrombosis, and may affect any tissue or organ. Coronary artery involvement, however, is very rare.
Vicens Martí +3 more
doaj +1 more source
S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty [PDF]
, 2002 Background: The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period.
Clifton, A. +4 more
core +1 more source
FLOW DIVERTER DEVICE IN THE ACUTE SETTING OF RUPTURED BLISTER LIKE ANEURYSM: A CASE REPORT [PDF]
Euromediterranean Biomedical Journal, 2021 Blister-like aneurysms (BLA) are a rare half-dome-shaped aneurysm, with a broad-based appearance, originating more often from a non-branching site of the supraclinoid internal carotid artery (ICA).
Cesare Gaglaiardo
doaj +1 more source
Are tirofiban and abciximab identical in efficacy? [PDF]
European Heart Journal, 2005 We read the paper by Mukherjee et al .1 on similar efficacy outcomes with tirofiban and ReoPro with a lot of interest and considerable reservations. The paper was hand-delivered to me by the representative of one of the drugs in the study with the proud claim that both drugs were equivalent.
openaire +3 more sources
Soluble CD40 ligand in acute coronary syndromes [PDF]
, 2003 BACKGROUND: CD40 ligand is expressed on platelets and released from them on activation. We investigated the predictive value of soluble CD40 ligand as a marker for clinical outcome and the therapeutic effect of glycoprotein IIb/IIIa receptor inhibition ...
Boersma, H. (Eric) +6 more
core +1 more source
Abciximab‐Associated Thrombocytopenia After Previous Tirofiban‐Related Thrombocytopenia [PDF]
, 2006 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90080/1/phco.26.3.423 ...
Dorsch, Michael P. +3 more
core +1 more source
Novel patient-centered approach to facilitate same-day discharge in patients undergoing elective percutaneous coronary intervention [PDF]
, 2018 Background Same‐day discharge ( SDD ) after elective percutaneous coronary intervention is safe, less costly, and preferred by patients, but it is usually performed in low‐risk patients,
Amin, Amit P +14 more
core +2 more sources
The use of combination of fibrinolytic therapy and abciximab in the treatment of the acute myocardial infarction with ST elevation [PDF]
Vojnosanitetski Pregled, 2002 Background. According to current knowledge, the best way to treat the acute myocardial infarction with ST elevation is primary transluminal coronary angioplasty, which can be performed only in the best equipped tertiary cardiology centers.
Gligić Branko +4 more
doaj +1 more source
BMC Cardiovascular Disorders, 2017 Background Thrombolysis is still used when primary angioplasty is delayed for a long time, but 25%–30% of patients require rescue angioplasty (RA). There are no established recommendations for antithrombotic management in RA.
José M. De la Torre Hernández +10 more
doaj +1 more source
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina [PDF]
, 2003 BACKGROUND: This study was designed to investigate long-term effects of the glycoprotein IIb/IIIa inhibitor abciximab in patients with acute coronary syndrome without ST elevation who were not scheduled for coronary intervention.
Armstrong, P.W. (Paul) +9 more
core +3 more sources